Siegfried Holding AG (LON:0QQO)
London · Delayed Price · Currency is GBP · Price in CHF 73.50
+1.29 (1.79%)
Dec 15, 2025, 2:36 PM BST
Siegfried Holding AG Revenue
Siegfried Holding AG had revenue of 619.52M CHF in the half year ending June 30, 2025, with 2.05% growth. This brings the company's revenue in the last twelve months to 1.29B, up 0.77% year-over-year. In the year 2024, Siegfried Holding AG had annual revenue of 1.29B with 1.82% growth.
Revenue (ttm)
1.29B CHF
Revenue Growth
+0.77%
P/S Ratio
2.54
Revenue / Employee
333.04K CHF
Employees
3,886
Market Cap
3.01B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.29B | 23.08M | 1.82% |
| Dec 31, 2023 | 1.27B | 41.98M | 3.41% |
| Dec 31, 2022 | 1.23B | 127.10M | 11.53% |
| Dec 31, 2021 | 1.10B | 257.36M | 30.45% |
| Dec 31, 2020 | 845.06M | 11.55M | 1.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Siegfried Holding AG News
- 10 months ago - Siegfried Holding AG (XSWX:SFZN) Full Year 2024 Earnings Call Highlights: Strong Profit Growth ... - GuruFocus